Skip to main content

Biological Effects of Recombinant Human Tumor Necrosis Factor on Human Bladder Cancer Cells

  • Conference paper
  • 79 Accesses

Abstract

The tumor necrosis factor (TNF) was detected by Carswell et al. (1975) in the serum of animals injected sequentially with bacillus Calmette-Guerin or Corynebacterium parvum and endotoxin. This treatment induces proliferation of macrophages, which are stimulated to secrete TNF by endotoxin (Beutler et al. 1986). TNF causes hemorrhagic necrosis of certain transplantable mouse and human tumors with no apparent effect on the host (Haranata et al. 1984). Partially purified preparations of human TNF as well as recombinant TNF have been shown to exhibit selective cytotoxic effects in vitro against several tumor cell lines with no cytotoxic effect on normal fibroblasts (Wang et al. 1985; Sugarman et al. 1985) but growth-enhancing effects on normal diploid skin (Detroit 551), lung (WI38), and foreskin (FS-4) fibroblastic cultures (Viket et al. 1986). Although the mechanism of selective toxicity of TNF to tumor cells is unknown, the selectivity is supposed to be at the TNF-receptor level.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander RB, Nelson WG, Coffey DS (1987a) Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. Cancer Res 47: 2403–2406

    PubMed  CAS  Google Scholar 

  • Alexander RB, Isaacs JT, Coffey DS (1987b) Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer. J Urol 138: 427–429

    PubMed  CAS  Google Scholar 

  • Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977–980

    Article  PubMed  CAS  Google Scholar 

  • Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3670

    Article  PubMed  CAS  Google Scholar 

  • Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68: 167–175

    Article  PubMed  CAS  Google Scholar 

  • Haranaka K, Satomi N, Sakurai A (1984) Antitumor activity of murine tumor necrosis factor ( TNF) against transplantable murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 34: 263–267

    Article  PubMed  CAS  Google Scholar 

  • Lee K-E, O’Donnell RW, Schoen S, Cockett ATK (1987) Effect of intravesical administration of tumor necrosis serum and human recombinant tumor necrosis factor on a murine bladder tumor. J Urol 138: 430–432

    PubMed  CAS  Google Scholar 

  • Liu LF (1983) DNA topoisomerases - enzymes that catalyze the breaking and rejoining of DNA. CRC Crit Rev Biochem 15: 1–24

    Article  PubMed  CAS  Google Scholar 

  • Ostrove JM, Gifford GE (1979) Stimulation of RNA synthesis in L929 cells by rabbit tumor necrosis factor. Proc Soc Exp Med 160: 354–358

    CAS  Google Scholar 

  • Ruff MR, Gifford GE (1981) Tumor necrosis factor. In: Pick E (ed) Lymphokines, vol 2. Academic, New York, pp 235–272

    Google Scholar 

  • Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM (1985) Recombinant tumor necrosis factor-a: effects on proliferation of normal and transformed cells in vitro. Science 230: 943–945

    Article  PubMed  CAS  Google Scholar 

  • Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466–468

    Article  PubMed  CAS  Google Scholar 

  • Vilcek J, Palombella V, Henriksen-Destefano D, Swenson C, Feinman R, Hirai M, Tsujimoto M (1986) Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163: 632–643

    Article  PubMed  CAS  Google Scholar 

  • Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, van Arsdell JN, Yamamoto R, Mark DF (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228: 149–154

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Heckl, W., Klossner, B., Halliger, B. (1989). Biological Effects of Recombinant Human Tumor Necrosis Factor on Human Bladder Cancer Cells. In: Rübben, H., Jocham, D., Jacobi, G.H. (eds) Investigative Urology 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74438-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74438-9_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74440-2

  • Online ISBN: 978-3-642-74438-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics